Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-15 of 15
Keywords: Central nervous system
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Article Collection: Thymus-Brain Connections in Health and Disease
,
Endocrinology
,
Immunology and Allergy
,
Neurology and Neuroscience
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2024) 31 (1): 51–61.
Published Online: 16 February 2024
... in the thymus since lymphoblasts express phenotypic markers comparable to those described in thymocytes in distinct stages of development. Although around 50% of T-ALL patients present a thymic mass, T-ALL is characterized by peripheral blood and bone marrow involvement, and central nervous system (CNS...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2023) 30 (1): 226–236.
Published Online: 20 September 2023
... has been linked to several inflammatory disorders. In human and rodents, the broad expression of IL-33 in spinal cord tissues and brain indicates its central nervous system-specific functions. Growing evidence supports the protective effects of the IL-33/ST2 pathway in ischemic stroke, along...
Journal Articles
Zifan Liu, Qingmei Huang, Huijuan Li, Wei Qiu, Baikeng Chen, Jie Luo, Huacai Yang, Tianni Liu, Si Liu, Huiming Xu, Youming Long, Cong Gao
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2018) 25 (2): 68–72.
Published Online: 26 July 2018
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Glutamic acid decarboxylase Antibody Myelitis Central nervous system Neoplasm Glutamic acid decarboxylase (GAD...
Journal Articles
Grasielle D. Menezes, Vanessa G. Goulart, Sheila Espírito-Santo, Priscilla Oliveira-Silva, Claudio Alberto Serfaty, Paula Campello-Costa
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2016) 23 (2): 81–87.
Published Online: 01 February 2016
... injection with IL-6 leads to sprouting in the subcortical visual connections and suggest that small changes in IL-6 levels might be sufficient to impair the correct neuronal circuitry fine-tuning during brain development. Interleukin-6 Central nervous system Retinotectal projections Plasticity...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2015) 22 (6): 358–364.
Published Online: 11 April 2015
... = 0.0001) but not of treatment (p > 0.05). The prefrontal cortex presented higher BDNF levels than other structures (ANOVA/Student-Newman-Keuls test, p = 0.0001). Considering the relationship between BDNF levels in all three structures, we found an effect of central nervous system structures (p = 0.01...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2013) 20 (2): 107–112.
Published Online: 28 December 2012
... = 0.005] or hrNMO + NMO (OR = 6.350, p = 0.028). Conclusion: H. pylori infection was present in most Chinese patients with NMO and hrNMO, and may be a risk factor for the NMO spectrum. Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) thought...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2011) 19 (1): 20–24.
Published Online: 07 November 2011
..., and b Department of Neurology, The First Affiliated Hospital of GuangDong Pharmaceutical University, Guangzhou, PR China Key Words Neuromyelitis optica Multiple sclerosis Aquaporin Central nervous system Abstract Background: Serum neuromyelitis optica immunoglobulin G (NMO-IgG) is used...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2010) 17 (2): 67–78.
Published Online: 17 November 2009
...André Luis Bombeiro; Maria Regina D’Império Lima; Gerson Chadi; José Maria Álvarez Background/Aim: Chagas’ disease is caused by Trypanosoma cruzi and occurs in most Latin American countries. The protozoan may colonize the central nervous system (CNS) of immune-compromised human hosts, thus causing...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2009) 16 (1): 1–12.
Published Online: 15 December 2008
... factors. In recent years, evidence has elucidated that some of these proteins as well as their receptors are also produced in the central nervous system (CNS) by specific neural cell lineages under physiological and pathological conditions. Cytokines regulate a variety of processes in the CNS, including...
Journal Articles
Markus J. Schwarz, Norbert Müller, Dirk Körschenhausen, Kathrin H. Kirsch, Randolph Penning, Manfred Ackenheil, Judith P. Johnson, Harald Hampel
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (1998) 5 (5): 270–276.
Published Online: 14 September 1998
... Key Words Adhesion molecules Transcription factor Central nervous system MUC18 MCAM CD146 Mader Egr-1 OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Abstract The proteins MUC18 and Mader have been identified as markers of tumor progression...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (1998) 5 (3-4): 126–135.
Published Online: 04 September 1998
...Iain L. Campbell; Anna K. Stalder; Yvette Akwa; Axel Pagenstecher; Valérie C. Asensio To better understand the actions of cytokines in the mammalian central nervous system (CNS), we have developed transgenic mice in which the expression of various cytokines including interleukin (IL)-3, IL-6, IL-12...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (1996) 3 (5): 304–309.
Published Online: 04 June 1997
..., instructions or products referred to in the content or advertisements. Interleukin-1 receptor accessory protein Central nervous system Lipopolysaccharides RT-PCR ...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (1996) 3 (2-3): 135–140.
Published Online: 08 November 1996
..., instructions or products referred to in the content or advertisements. Tumor necrosis factor-α Hyperalgesia Prostaglandin Interleukin-1 Pain Central nervous system Rat ...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (1996) 3 (2-3): 69–75.
Published Online: 08 November 1996
...Paul E. Gottschall; Suman Deb In neurodegenerative disease or after brain injury, parenchymal cells in the central nervous system are activated to produce inflammatory mediators, mainly consisting of cytokine-induced factors, in a manner similar to, but clearly different from a peripheral...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (1995) 2 (3): 161–165.
Published Online: 20 November 1995
..., instructions or products referred to in the content or advertisements. Interleukin Tumor necrosis factor-α Central nervous system Transport Brain Endothelium Saturable Mouse Human ...